Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease.

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease.
Related ArticlesDysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease. Front Neurosci. 2019;13:328 Authors: Alecu I, Bennett SAL Abstract Parkinson's disease (PD) is the second most common neurodegenerative disease, the main pathological hallmark of which is the accumulation of α-synuclein (α-syn) and the formation of filamentous aggregates called Lewy bodies in the brainstem, limbic system, and cortical areas. ... read more
Source: PubMedPublished on 2019-04-30